Scientists are pushing the boundaries of genetic engineering with an ambitious plan to resurrect the woolly mammoth by 2028.

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an ...

Colossal Biosciences, a company based in Dallas, recently received a $200 million investment to work on a project that might ...

The woolly mammoth, a giant that roamed the icy expanses of the planet during the Pleistocene epoch, became extinct around 4,000 years ago and is at the center of Colossal’s mission. It’s a ...

Woolly mammoth meat hasn't been on the menu for at least 5,000 years. A lab-grown meat company called Vow recently appeared to put the option back on the table by creating a "mammoth meatball ...

A prehistoric creature has just provided a stunning breakthrough, as a new research paper reveals that scientists mapped the three-dimensional architecture of a woolly mammoth's genome using ...

“But tomorrow it’ll be causing economic effects.” Perhaps known best for its efforts to bring back the woolly mammoth, Dallas-based Colossal’s core mission is preserving biodiversity ...

The following is an edited transcript of their conversation. Nova Safo: So you’re not exactly bringing back the woolly mammoth. You’re creating a new hybrid. Is that right? Ben Lamm ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Colossal Biosciences, which is known for its plans to revive extinct animals, says that ...

Woolly Mammoth Theatre is celebrating its 45th year and is also marking 20 years in its D Street NW building. It’s hard to imagine something more fitting for Woolly Mammoth Theatre’s stage ...

Guitar solos may be a leitmotif in “Guac,” at Woolly Mammoth Theatre Company, but the play’s workings are more symphonic. Chalk the synthesizing up to the trenchant but highly entertaining ...